Time to initiation of antiretroviral therapy among patients with HIV-associated tuberculosis in Cape Town, South Africa
Data(s) |
2011
|
---|---|
Resumo |
We studied the time interval between starting tuberculosis treatment and commencing antiretroviral treatment (ART) in HIV-infected patients (n = 1433; median CD4 count 71 cells per microliter, interquartile range: 32-132) attending 3 South African township ART services between 2002 and 2008. The overall median delay was 2.66 months (interquartile range: 1.58-4.17). In adjusted analyses, delays varied between treatment sites but were shorter for patients with lower CD4 counts and those treated in more recent calendar years. During the most recent period (2007-2008), 4.7%, 19.7%, and 51.1% of patients started ART within 2, 4, and 8 weeks of tuberculosis treatment, respectively. Operational barriers must be tackled to permit further acceleration of ART initiation as recommended by 2010 WHO ART guidelines. |
Formato |
application/pdf |
Identificador |
http://boris.unibe.ch/7315/1/Lawn%20JAcquirImmuneDeficSyndr%202011.pdf Lawn, Stephen D; Campbell, Lucy; Kaplan, Richard; Boulle, Andrew; Cornell, Morna; Kerschberger, Bernhard; Morrow, Carl; Little, Francesca; Egger, Matthias; Wood, Robin (2011). Time to initiation of antiretroviral therapy among patients with HIV-associated tuberculosis in Cape Town, South Africa. Journal of acquired immune deficiency syndromes JAIDS, 57(2), pp. 136-140. Philadelphia, Pa.: Lippincott Williams & Wilkins 10.1097/QAI.0b013e3182199ee9 <http://dx.doi.org/10.1097/QAI.0b013e3182199ee9> doi:10.7892/boris.7315 info:doi:10.1097/QAI.0b013e3182199ee9 info:pmid:21436714 urn:issn:0894-9255 |
Idioma(s) |
eng |
Publicador |
Lippincott Williams & Wilkins |
Relação |
http://boris.unibe.ch/7315/ |
Direitos |
info:eu-repo/semantics/restrictedAccess |
Fonte |
Lawn, Stephen D; Campbell, Lucy; Kaplan, Richard; Boulle, Andrew; Cornell, Morna; Kerschberger, Bernhard; Morrow, Carl; Little, Francesca; Egger, Matthias; Wood, Robin (2011). Time to initiation of antiretroviral therapy among patients with HIV-associated tuberculosis in Cape Town, South Africa. Journal of acquired immune deficiency syndromes JAIDS, 57(2), pp. 136-140. Philadelphia, Pa.: Lippincott Williams & Wilkins 10.1097/QAI.0b013e3182199ee9 <http://dx.doi.org/10.1097/QAI.0b013e3182199ee9> |
Tipo |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion PeerReviewed |